daunorubicin has been researched along with difloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gollapudi, S; Gupta, S; Kim, CH; Thadepalli, F | 1 |
| Gilbert, J; Haber, M; Madafiglio, J; Marshall, GM; Norris, MD | 1 |
2 other study(ies) available for daunorubicin and difloxacin
| Article | Year |
|---|---|
Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene.
Topics: Anti-Infective Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Ciprofloxacin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoroquinolones; Gene Expression; HL-60 Cells; Humans; Microscopy, Confocal; Quinolones; Vincristine | 1995 |
Reversal of multidrug resistance-associated protein-mediated drug resistance in cultured human neuroblastoma cells by the quinolone antibiotic difloxacin.
Topics: Adenocarcinoma; Anti-Infective Agents; Antimony Potassium Tartrate; ATP-Binding Cassette Transporters; Breast Neoplasms; Ciprofloxacin; Cisplatin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoroquinolones; Gene Amplification; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neuroblastoma; Polymerase Chain Reaction; Substrate Specificity; Tumor Cells, Cultured; Vincristine | 2001 |